Literature DB >> 792494

Effect of cephalothin on growth patterns of micro-organisms.

G P Bodey, T Pan.   

Abstract

Isolates of Staphylococcus aureus, Escherichia coli. Klebsiella pneumoniae and Proteus mirabilis were incubated in the presence of inhibitory concentrations of cephalothin. After destruction of the antibiotic, there was a lag phase before S. aureus began to proliferate again. When similar experiments were conducted with E. coli, K. pneumoniae, and P. mirabilis, no lag phase was observed. This data suggests that the inhibitory activity of cephalosporins may be different for gram-positive cocci and gram-negative bacilli.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 792494     DOI: 10.7164/antibiotics.29.1092

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  Post-antibiotic effect of ciprofloxacin on Pseudomonas aeruginosa.

Authors:  K Fuursted
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

2.  In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.

Authors:  H R Stutman; J C Akaniro; C E Vidaurre; M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

3.  Postantibiotic effect of ceftriaxone and gentamicin alone and in combination on Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus viridans.

Authors:  A Buxbaum; A Georgopoulos
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

4.  Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo.

Authors:  J Renneberg; M Walder
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

Review 5.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

6.  Postantibiotic effect of imipenem on Pseudomonas aeruginosa.

Authors:  C I Bustamante; G L Drusano; B A Tatem; H C Standiford
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

7.  Comparison of two schedules of cefoperazone plus aztreonam in the treatment of neutropenic patients with fever.

Authors:  G Bodey; A Reuben; L Elting; H Kantarjian; M Keating; F Hagemeister; C Koller; W Velasquez; N Papadopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-07       Impact factor: 3.267

8.  Pharmacokinetics of cefoperazone in patients with neoplastic disease.

Authors:  A W Maksymiuk; B M LeBlanc; N S Brown; D H Ho; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1981-06       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.